(13-090) Head-to-Head: Atorvastatin vs. Rosuvastatin for Secondary Stroke Prevention in Patients with Acute Ischemic Stroke (AIS)
Wednesday, December 10, 2025
3:15 PM - 4:15 PM
Location: Bayside A, Level 1
Residency Program: University of Tennessee Medical Center Residency Program Type: PGY1 & PGY2 Combined (PGY1 Pharmacy & PGY2 Pharmacotherapy) Residency Program Location: Tennessee
Co-Author(s): Erin Belden, Leslie Hamilton, Thaddeus McGiness, Courtney Weaver